Glucagon‐like peptide‐1 ( GLP ‐1) is an incretin hormone whose glucose‐dependent insulinotropic actions have been harnessed as a novel therapy for glycaemic control in type 2 diabetes. Although it has been known for some time that the GLP ‐1 receptor is expressed in the CVS where it mediates impo…